OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD

dc.contributor.authorPakeerathan T.
dc.contributor.authorDavis J.
dc.contributor.authorHenderson A.D.
dc.contributor.authorSotirchos E.S.
dc.contributor.authorSaid Y.
dc.contributor.authorHavla J.
dc.contributor.authorRingelstein M.
dc.contributor.authorAktas O.
dc.contributor.authorWeise M.
dc.contributor.authorGernert J.A.
dc.contributor.authorKornek B.
dc.contributor.authorBsteh G.
dc.contributor.authorRommer P.S.
dc.contributor.authorKrajnc N.
dc.contributor.authorPröbstel A.K.
dc.contributor.authorPapadopoulou A.
dc.contributor.authorKulsvehagen L.
dc.contributor.authorPretzsch R.
dc.contributor.authorSchoenholzer K.
dc.contributor.authorPadungkiatsagul T.
dc.contributor.authorMoss H.E.
dc.contributor.authorVillarreal Navarro S.E.
dc.contributor.authorHerwerth M.
dc.contributor.authorGraure M.
dc.contributor.authorKana V.
dc.contributor.authorStiebel-Kalish H.
dc.contributor.authorZlatkin R.
dc.contributor.authorArnold A.C.
dc.contributor.authorBonelli L.
dc.contributor.authorStellmann J.P.
dc.contributor.authorStolowy N.
dc.contributor.authorSchwake C.
dc.contributor.authorSchneider-Gold C.
dc.contributor.authorKümpfel T.
dc.contributor.authorAlbrecht P.
dc.contributor.authorRattanathamsakul N.
dc.contributor.authorPittock S.J.
dc.contributor.authorFlanagan E.P.
dc.contributor.authorCarta S.
dc.contributor.authorMariotto S.
dc.contributor.authorGold R.
dc.contributor.authorChen J.J.
dc.contributor.authorAyzenberg I.
dc.contributor.correspondencePakeerathan T.
dc.contributor.otherMahidol University
dc.date.accessioned2026-02-06T18:17:15Z
dc.date.available2026-02-06T18:17:15Z
dc.date.issued2026-03-01
dc.description.abstractBACKGROUND AND OBJECTIVES: Severe optic neuritis (ON) is a common clinical manifestation in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorder (NMOSD). Given distinct prognoses and often the necessity of early plasma exchange in NMOSD, prompt differentiation is crucial. In this study, we investigated the utility of optical coherence tomography (OCT) in differentiating between first acute NMOSD-ON and MOGAD-associated optic neuritis (MOGAD-ON), as well as specific factors associated with disc edema. METHODS: In this retrospective multicenter study, 111 adult patients with MOGAD or aquaporin-4 antibody-positive NMOSD who experienced a first ON and underwent OCT within 2 weeks of symptom onset were included from 14 centers across 8 countries. Peripapillary retinal nerve fiber layer (pRNFL) thickness in µm was analyzed, including the average of both eyes in cases of bilateral manifestation. RESULTS: Eighty-three patients with MOGAD (51 women; 124 ON eyes; bilateral ON 48.2%) and 28 with NMOSD (24 women; 36 ON eyes; bilateral ON 21.4%) were enrolled. A significant increase in pRNFL thickness (>2SD), suggestive of disc edema, was observed in 73.4% of MOGAD-ON eyes and 11.1% of NMOSD-ON eyes (p < 0.001). The pRNFL thickness cutoff of 117.5 µm provided 92.9% specificity and 71.1% sensitivity in distinguishing between MOGAD-ON and NMOSD-ON (area under the curve = 0.838). There was no association between pRNFL thickening and MOG-IgG titer (high vs low), body mass index, or the delay between ON onset and OCT. Simultaneous bilateral MOGAD-ON was associated with significantly more pronounced pRNFL thickening. DISCUSSION: Acute-stage OCT contributes to the rapid and accurate differentiation between MOGAD-ON and NMOSD-ON prior to antibody confirmation, which can be critical for timely therapeutic decisions.
dc.identifier.citationNeurology R Neuroimmunology Neuroinflammation Vol.13 No.2 (2026) , e200531
dc.identifier.doi10.1212/NXI.0000000000200531
dc.identifier.eissn23327812
dc.identifier.pmid41499724
dc.identifier.scopus2-s2.0-105026946295
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/114493
dc.rights.holderSCOPUS
dc.subjectNeuroscience
dc.subjectMedicine
dc.titleOCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105026946295&origin=inward
oaire.citation.issue2
oaire.citation.titleNeurology R Neuroimmunology Neuroinflammation
oaire.citation.volume13
oairecerif.author.affiliationStanford University
oairecerif.author.affiliationJohns Hopkins University
oairecerif.author.affiliationMayo Clinic
oairecerif.author.affiliationTel Aviv University
oairecerif.author.affiliationUniversität Bonn
oairecerif.author.affiliationMedizinische Universität Wien
oairecerif.author.affiliationKlinikum der Universität München
oairecerif.author.affiliationHeinrich-Heine-Universität Düsseldorf
oairecerif.author.affiliationUniversità degli Studi di Verona
oairecerif.author.affiliationUniversitätsspital Basel
oairecerif.author.affiliationHopital La Timone
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationDeutsches Zentrum für Neurodegenerative Erkrankungen
oairecerif.author.affiliationWilmer Eye Institute
oairecerif.author.affiliationUCLA Stein Eye Institute
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University
oairecerif.author.affiliationSt. Josef-Hospital im Katholischen Klinikum Bochum
oairecerif.author.affiliationHeinrich-Heine-Universität Düsseldorf Medizinische Fakultät
oairecerif.author.affiliationUniversitätsspital Zürich, Klinik für Neurologie
oairecerif.author.affiliationCentre de Résonance Magnétique Biologique et Médicale
oairecerif.author.affiliationMaria Hilf Clinics Mönchengladbach

Files

Collections